Parkinsonism in Ontario: Increased mortality compared with controls in a large cohort study

Neurology

Volumn 57, Issue 12, 2001, Pages 2278-2282

  Guttman, M ^a,d   Slaughter, P M ^c   Theriault, M E ^c   DeBoer, D P ^c   Naylor, C D ^b  

^a Division of Neurology   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; CANADA; CONTROLLED STUDY; EVALUATION; FOLLOW UP; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PARKINSONISM; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0035956501     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.12.2278     Document Type: Article

References (22)

1. Parkinson's disease. First of two parts
2. Parkinson's disease. Second of two parts
3. The natural history of Parkinson's disease
4. Parkinsonism. Onset, progression, and mortality
5. Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease
6. Epidemiology of parkinsonism: Incidence, classification and mortality
7. Multi-center study of Parkinson mortality with early versus later dopa treatment
8. Mortality in patients with Parkinson's disease
9. Mortality in a population- based cohort of patients treated with antiparkinsonian drugs
10. Parkinson's disease in Aberdeen: Survival after 3.5 years
11. Survival and cause of death in a cohort of patients with parkinsonism: Possible clues to aetiology?
12. The Sydney multicentre study of Parkinson's disease: Progression and mortality at 10 years
13. Mortality from Parkinson disease
14. Prognosis with Parkinson's disease in Europe: A collaborative study of population-based cohorts
15. Selegiline and mortality in subjects with Parkinson's disease
16. Mortality in DATATOP: A multicenter trial in early Parkinson's disease
17. Accuracy of clinical diagnosis in parkinsonism-A prospective survey
18. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinicopathological study of 100 cases
19. Prevalence of parkinsonian signs and associated mortality in a community population of older people
20. Mortality in people taking selegiline: Observational study
21. Patterns of health care in Ontario
22. Technical appendix